Welcome to the Company Emerging Market Analysis Dashboard!

The goal of this dashboard of providing EMBU colleagues worldwide a set of tools to readily access uniform market, competitor and Company performance data and analyses for Emerging Markets. We see this tool as the start of a process that will allow all of us within the EMBU community to have ready access to current and historical performance data and reports and because of its interactive features to readily create new customized analyses.
We will need your suggestions of how to make this tool more useful going forward, so please tell us what works, what does not, what needs to be changed.

Using the Toolset:

  • Step #1:Choose a Database Quarterly or Monthly.All data in this dashboard is derived from IMS Health Midas Databases, but since the coverage of geographic markets and channels varies between IMS’s monthly and quarterly databases you need to first choose one database or the other.
  • Step #2:Choose whether you want to see performance of Company and competitor companies by choosing Competitors; or performance of products by choosing Products.


This module allows you to see the performance of Company or a single competitor across different geographic markets, both regional and individual countries; or to see Company and its competitors within a single geographic market, either a region (e.g. Emerging Markets, BRICMT) or a country.
Choose Across Geographies to see either Company’s or one of its competitors’ performance across several geographic markets.
Choose Within a Geography to see Company and/or its competitors’ performance within one geographic market, be it, regional or a country.

The tools below will allow use to define:

Time Period: The Select Time Period tool allows you to view metrics by individual quarters, year-to-date, moving annual total (MAT). Depending on the time frame chosen, five to six years of data is provided.
Metrics:The Select Metrics tool allows you to change between Sales Revenues, Market Share (%), Growth (%) and Evolution Index (EI).
Companies:The Select Custom Corps tool allows you to select which companies, including Company, you want to analyze.
You can also view all metrics within one time frame (Snapshot View) or one metric over several time frames by toggling between (Trend View) by selecting Trend or Snapshot.


Similar to the Competitor module, the tools in the Products section will allow you to define:

Time Periods
Revenues or Unit Volume Views.New in this module is the ability to select performance metrics for both revenues and unit volumes. In this way, you can see Growth, Market Share and EI performance along both axes.
Individual products including those of competitors.
Trend View
SnapShot View

The dashboard also serves as a depository for Key EM Reports and Documents that can be located by choosing the “Key Reports” tab on the top left of the Home Page. These include:

  • Company EM Performance Reports
  • Market by Product
  • Product by Market

Important Information on Data Methodology and Limitations:

  • IMS data is based on sample audits of the market and often incomplete audits. It, therefore, will tend to understate the actual size of the pharmaceutical markets, product segments and of companies within those markets.
  • IMS data will not match and, with certain exceptions, show amounts that will not match internal Company data for the same market.
  • In most countries, IMS audits measure sales from the wholesaler to the retailer and not direct sales from the manufacturer to the retailer. IMS standardizes the data so that all sales are represented at the ex-manufacturer level for all countries for consistency purposes. In general, IMS audited sales do not reflect the early stocking of new products that is encountered in the markets.
  • Revenue calculation. The revenue data is based on ex-manufacturer prices. It does not contain mark up at the wholesale or retail level. IMS also cannot account for rebates or discounts, so in markets where those sales incentives are heavily employed, the IMS data may overstate actual product revenue.
  • Currency conversions. All sales are reported in “local constant dollars”; i.e. US$ calculated at the average constant exchange rate for the most recent period available.
  • Product types included. Sales in this report account for prescription (i.e. ethical) products only to the extent possible (excluding non-prescription or OTC products).
  • Product Exclusions. Two therapeutic categories (i.e. ATCs) within ethical pharmaceuticals are not included in these data: V6 and V7.
  • Co-promoted products. Total Company sales (by area, region and country) include a portion of Aricept, Spiriva and Zorem sales based on promotional effort by country.
  • Revenues excluded. Company sales do not include Mack Export
  • Key calculations. Market share, rank and growth are based on total brand sales. All products use the IMS INTPRD (i.e. International Product Name) classification. Market shares and ranks for the products are based on therapeutic market definitions provided by Company Global Market Analytics.
The data in this tool set does, however, have important limitations that we must bear in mind when using it. These are:
  • Monthly vs Quarterly Databases. In the monthly databases data is not available for as many markets and channels as in the quarterly reports. No data is available in the monthly databases, for example, for Malaysia, Singapore, Indonesia, Hong Kong, Taiwan, Pakistan, and Thailand. Also no channel data is available, in the monthly modules, for Russia Hospital and DLO; Turkey Hospital; Philippines Hospital; and South Africa Hospital.
  • Totals and Subtotals. Emerging Market, sub-regional, commercial unit and product totals only reflect the data that is available. Therefore, regional totals in the monthly reports can reflect a different mix of markets than in quarterly reports.
  • Metrics derived from segment aggregates (e.g. Evolution Index) only reflect those markets for which data is available on a monthly basis.
  • Channel coverage. Not all channels or market segments are available for all countries. The channels/segments that are covered in each country are as follows:
    • AfME
      • Algeria = Retail
      • Egypt = Retail
      • Jordan = Retail
      • Kuwait = Retail
      • Lebanon = Retail
      • Morocco = Retail
      • South Africa = Retail + Hospital (Includes retail sales data only in monthly reports)
      • Saudi Arabia = Retail
      • Tunisia = Retail
      • United Arab Emirates = Retail
      • West Africa Subregion = Retail
    • Asia
      • China = Hospital
      • Hong Kong = Retail + Hospital (only available quarterly)
      • India = Retail
      • Indonesia = Retail + Hospital (only available quarterly)
      • Malaysia = Retail + Hospital (only available quarterly)
      • Pakistan = Retail (only available quarterly)
      • Philippines = Retail + Hospital (Includes retail sales data only in monthly reports)
      • Singapore = Retail + Hospital (only available quarterly)
      • Taiwan = Retail + Hospital (only available quarterly)
      • Thailand = Retail + Hospital (only available quarterly)
    • EM Europe
      • Bulgaria = Retail + Hospital
      • Croatia = Retail + Hospital
      • Czech Rep = Retail + Hospital
      • Estonia = Retail
      • Hungary = Retail + Hospital
      • Latvia = Retail + Hospital
      • Lithuania = Retail + Hospital
      • Poland = Retail + Hospital
      • Romania = Retail
      • Russia = Retail + Hospital + DLO (Includes retail sales data only in monthly reports)
      • Slovakia = Retail + Hospital
      • Slovenia = Retail + Hospital
      • Turkey = Retail + Hospital (Includes retail sales data only in monthly reports)
    • Latin America
      • Argentina = Retail
      • Brazil = Retail
      • Central America Sub Region = Retail
      • Chile = Retail
      • Colombia = Retail
      • Ecuador = Retail
      • Mexico = Retail
      • Peru = Retail
      • Venezuela = Retail
    • *For countries not included in the list above, IMS does not provide us data.